QR Code https://tubittumjournal.com/article/1107
Research Article

Naturopathic Approaches in the Management of Polycystic Ovary Syndrome: A Narrative Review

Authors

  • Sedigheh Bahmaei Kamaei
Sedigheh Bahmaei Kamaei

Abstract

Abstract

Background: Polycystic ovary syndrome (PCOS) is a common endocrine–metabolic disorder that affects reproductive health, insulin sensitivity, and systemic inflammatory processes. Naturopathic interventions—including nutritional therapies, herbal medicine, targeted supplementation, and lifestyle modification—have gained increasing interest as complementary strategies to address the multifactorial nature of PCOS.

Objective: This review synthesizes evidence published between 2015 and 2025 on the effectiveness of key naturopathic interventions—such as inositol, berberine, vitamin D, omega-3 fatty acids, and lifestyle modification—in improving metabolic, hormonal, and clinical outcomes in women with PCOS.

Methods: A structured literature search was conducted in PubMed, Scopus, and Google Scholar. Fifteen eligible studies, including clinical trials and systematic reviews, were selected and qualitatively analyzed based on relevance to PCOS-related endocrine and metabolic outcomes.

Results: The reviewed interventions demonstrated potential benefits in reducing insulin resistance, lowering androgen levels, improving lipid profiles, decreasing inflammation, and enhancing ovulatory function. Inositol and berberine, in particular, showed the most consistent metabolic improvements across the included studies.

Conclusion: Naturopathic interventions represent promising complementary options for managing PCOS, offering improvements in both metabolic and reproductive parameters. However, further high-quality randomized trials are required to determine optimal dosing, treatment duration, and comparative efficacy among different therapies.

Files :

Copyright © 2022 Tubittum Journal. All rights reserved.

Authors retain copyright of their article if they are accepted for publication.

This work is licensed under a Creative Commons Attribution 4.0 International License.

Creative Commons License

Bahmaei Kamaei S. Naturopathic Approaches in the Management of Polycystic Ovary Syndrome: A Narrative Review. 2025;4(4):132-149. Doi:10.64209/tubittum.v4i4.1107

References:

  1. Fitz V, Graca S, Mahalingaiah S, Liu J, Lai L, Butt A, et al. Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines. J Clin Endocrinol Metab. 2024;109(6):1630–1655. doi:10.1210/clinem/dgad762
  2. Greff D, Juhász AE, Váncsa S, Erőss B, Hegyi P, Szakács Z, et al. Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Reprod Biol Endocrinol. 2023;21:10. doi:10.1186/s12958-023-01055-z
  3. Di Pierro F, Belcaro G, Lelli A, Cacchio M, Dugall M, Togni S, et al. Effect of Berberine Phytosome® on reproductive, dermatologic, and metabolic characteristics in women with polycystic ovary syndrome: a controlled, randomized, multi-centric, open-label clinical trial. Front Pharmacol. 2023;14:1269605. doi:10.3389/fphar.2023.1269605
  4. Zhou J, Sun X, Zhang D, Xu J, Li X, Li H. Effects of n-3 polyunsaturated fatty acid on metabolic status in women with PCOS: a meta-analysis of randomized controlled trials. J Ovarian Res. 2023;16:130. doi:10.1186/s13048-023-01130-4
  5. Huang Y, Zhang X. Meta-analysis of the efficacy of ω-3 polyunsaturated fatty acids when treating patients with polycystic ovary syndrome. Medicine (Baltimore). 2023;102(39):e35403. doi:10.1097/MD.0000000000035403
  6. Ebrahimi FA, Samimi M, Foroozanfard F, Akbari H, Rahmani E, Asemi Z. The effects of omega-3 fatty acids and vitamin E co-supplementation on indices of insulin resistance and hormonal parameters in patients with PCOS: a randomized, double-blind, placebo-controlled trial. Exp Clin Endocrinol Diabetes. 2017;125(6):e3–e8. doi:10.1055/a-1736-9502
  7. Maktabi M, Chamani M, Aghadavod E, Asemi Z. Effects of vitamin D supplementation on metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Horm Metab Res. 2017;49(7):493–498. doi:10.1055/s-0043-107242
  8. Miao CY, Li PJ, Li F, et al. Effect of vitamin D supplementation on polycystic ovary syndrome: insulin resistance, hyperandrogenism and lipid metabolism. Exp Ther Med. 2020;19:2178–2184. doi:10.3892/etm.2020.8525
  9. Li MF, Zhou XM, Li XL, Lu S. The effect of berberine on polycystic ovary syndrome patients with insulin resistance (PCOS-IR): a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2018;2018:2532935. doi:10.1155/2018/2532935
  10. Rondanelli M, Riva A, Petrangolini G, Allegrini P, Giacosa A, Fazia T, et al. Berberine phospholipid is an effective insulin sensitizer and improves metabolic and hormonal disorders in women with polycystic ovary syndrome: a one-group pretest–post-test explanatory study. 2021;13(10):3665. doi:10.3390/nu13103665
  11. Kachhawa G, Rajender S, Deka D. Efficacy of myo-inositol and D-chiro-inositol combination on menstrual cycle regulation and improving insulin resistance in young women with polycystic ovary syndrome: a randomized open-label study. Int J Gynaecol Obstet. 2022;158(2):278–284. doi:10.1002/ijgo.13971
  12. Nordio M, Basciani S. The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios. Eur Rev Med Pharmacol Sci. 2019;23(12):5512–5521. doi:10.26355/eurrev_201906_18223
  13. Monastra G, Vucenik I, Harrath AH, Alwasel SH, Kamenov ZA, Laganà AS, et al. PCOS and inositols: controversial results and necessary clarifications. Front Endocrinol (Lausanne). 2021;12:660381. doi:10.3389/fendo.2021.660381
  14. Fedeli V, Catizone A, Querqui A, Unfer V, Bizzarri M. The role of inositols in the hyperandrogenic phenotypes of PCOS: a re-reading of Larner’s results. Int J Mol Sci. 2023;24(7):6296. doi:10.3390/ijms24076296
  15. Albardan L, Platat C, Kalupahana NS. Role of omega-3 fatty acids in improving metabolic dysfunctions in polycystic ovary syndrome. 2024;16(17):2961. doi:10.3390/nu16172961

 

Articles Search

Search with Article name or description

Search with Author's name